FTO can also down‐regulate the m6A level of human hepatoma cells HepG2, reduce mitochondrial content, and increase triglyceride deposition, which provides a new idea for the early prevention of NAFLD.13 Here, FTO is linked to metabolic dysfunction-associated steatotic liver disease.